20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.
about
Emerging data on androgen receptor splice variants in prostate cancerAndrogen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells.Splicing variants of androgen receptor in prostate cancer.Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancerGinsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.Methylselenocysteine preventing castration-resistant progression of prostate cancerGaleterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation.Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer.Decoding the androgen receptor splice variants.Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors.
P2860
Q28077830-A865515C-4474-4871-97DE-CF6B3026E37DQ33688956-DCDEEB1F-282D-4819-887E-2BBB08560B9DQ33821011-505EB1D8-0BBC-4BB9-A375-4A85053486DDQ34448143-4563AA31-932B-42C5-9D08-6D89F1772567Q34663140-3D1EB188-343F-40C4-AC57-716514AF565DQ35290630-C1851B7E-E7D3-47C0-A89C-E6FC70ECB9DAQ35399276-DAC5C192-4562-4270-9531-DABCA1DB734DQ35582612-7656D741-4AA3-438D-8D2B-0062AB881928Q36413805-73085FAA-C1F3-4CC0-8CDF-3EC5DE39F138Q37123841-6A04C792-2D62-4D78-AC19-96A86959552DQ38114780-C0439139-41C5-4A44-8A54-CA28990D1883Q38263870-17E28E98-5091-44E6-A6F5-71E60B6D1B08Q38361928-7D218719-D672-4E1E-97A7-7F156E00D9C0Q53681652-DDC62B30-CD84-4E68-BEF6-97507EEFE969
P2860
20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor.
@ast
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor.
@en
type
label
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor.
@ast
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor.
@en
prefLabel
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor.
@ast
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor.
@en
P2093
P2860
P356
P1476
20(S)-protopanaxadiol-aglycone ...... variants of androgen receptor
@en
P2093
Allen Zhang
Benjamin R Lee
Clement Ip
Haitao Zhang
Jingkai Gu
Lijuan Zhao
Oliver Sartor
Paul S Rennie
Shuang Liu
P2860
P304
P356
10.1002/IJC.27754
P50
P577
2012-08-20T00:00:00Z